COVID-19/SARS-COV-2 / LETTER TO THE EDITOR
Cancer screening coverage in Poland – from bad to
better to the worst during the SARS-CoV-2 pandemic
| 1 | Department of Cancer Epidemiology and Primary Prevention, Maria Sklodowska-Curie
National Research Institute of Oncology, Warsaw, Poland |
| 2 | Cancer Prevention Department, Maria Sklodowska-Curie National Research Institute
of Oncology, Warsaw, Poland |
| 3 | Department of Social Medicine and Public Health, Doctoral School, Medical
University of Warsaw, Warsaw, Poland |
CORRESPONDING AUTHOR
Submission date: 2020-09-29
Final revision date: 2021-03-12
Acceptance date: 2021-03-13
Online publication date: 2021-04-08
Publication date: 2021-07-16
Arch Med Sci 2021;17(4):1132–1133
TOPICS
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.